LENZ Therapeutics, Inc. (LENZ)
5.11
+0.30
(+6.24%)
USD |
NASDAQ |
Aug 28, 16:00
5.08
-0.03
(-0.59%)
After-Hours: 20:00
LENZ Therapeutics Cash from Investing (Quarterly) : 37.75M for June 30, 2026
Cash from Investing (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 37.75M |
| March 31, 2026 | 33.16M |
| December 31, 2025 | -89.81M |
| September 30, 2025 | -4.333M |
| June 30, 2025 | -0.414M |
| March 31, 2025 | 18.89M |
| December 31, 2024 | -11.86M |
| September 30, 2024 | -62.23M |
| June 30, 2024 | -98.39M |
| March 31, 2024 | 18.00M |
| December 31, 2023 | 15.17M |
| September 30, 2023 | -17.91M |
| June 30, 2023 | -26.88M |
| Date | Value |
|---|---|
| March 31, 2023 | -0.006M |
| December 31, 2022 | 13.52M |
| September 30, 2022 | 3.496M |
| June 30, 2022 | -88.22M |
| March 31, 2022 | -170.67M |
| December 31, 2021 | -0.981M |
| September 30, 2021 | -3.636M |
| June 30, 2021 | -0.763M |
| March 31, 2021 | -0.36M |
| December 31, 2020 | -0.612M |
| September 30, 2020 | -0.554M |
| June 30, 2020 | -0.379M |
| March 31, 2020 | 0.00 |
Cash From Investing Definition
Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Ocular Therapeutix, Inc. | -3.367M |
| Enveric Biosciences, Inc. | 0.00 |
| Liquidia Corp. | -12.24M |
| Aquestive Therapeutics, Inc. | -0.212M |
| Impact BioMedical, Inc. | 0.002M |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -38.71M |
| Cash from Financing (Quarterly) | 0.395M |
| Free Cash Flow | -114.42M |
| Free Cash Flow Per Share (Quarterly) | -1.234 |
| Free Cash Flow to Equity (Quarterly) | -38.62M |
| Free Cash Flow to Firm (Quarterly) | -38.73M |
| Free Cash Flow Yield | -73.21% |